Indianapolis, IN, United States of America

Paul Douglas Walling

This inventor holds 7 USPTO granted patents, plus 4 CIPO patents and 4 EPO patents. Top assignees: Roche Diagnostics Operations, Inc., Roche Operations Ltd.. Active years: 2011-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Douglas Walling. Retrieved from https://idiyas.com/inventor/paul-douglas-walling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7

% Patents Active = 57.1

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 87(Granted Patents)

Company Filing History:

7 out of 1,700

Roche Diagnostics Operations, Inc.

patents

4 out of 44

Roche Operations Ltd.

patents

where one patent can have more than one assignee

Years Active: 2011-2014

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8775095 - Methods and apparatus for decentralized diabetes monitoring (2014-07-08),

2. 8551308 - Biosensor and method of making (2013-10-08),

3. 8506775 - Devices and methods relating to electrochemical biosensors (2013-08-13),

4. 8287703 - Biosensor and method of making (2012-10-16),

5. 8222044 - Test strip with flared sample receiving chamber (2012-07-17),

6. 8071030 - Test strip with flared sample receiving chamber (2011-12-06),

7. 7867369 - Biosensor with multiple electrical functionalities (2011-01-11),

Title: Profile of Inventor Paul Douglas Walling

Introduction: Paul Douglas Walling is a prominent figure in the realm of innovation and research based in the United States. Currently, he is associated with F. Hoffmann-La Roche AG, a leading global healthcare company.

Latest Patents: As of now, Paul Douglas Walling holds zero patents. However, his contribution to the field of research and development remains significant through his work and collaborations.

Career Highlights: Paul has made notable contributions during his tenure at F. Hoffmann-La Roche AG. His keen insights and expertise have been instrumental in advancing various projects within the organization.

Collaborations: Throughout his career, Paul has worked alongside esteemed coworkers, including Raghbir Singh Bhullar and Nigel A. Surridge. These collaborations have fostered a dynamic environment conducive to innovation and development.

Conclusion: Paul Douglas Walling continues to be an influential member of the scientific community, contributing to advancements in healthcare and related fields through his work at F. Hoffmann-La Roche AG. His journey exemplifies the spirit of innovation and collaboration that drives progress in today's world.

Profile summary based on public USPTO records.